Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by OSTFELD, A. M.
Right arrow Articles by WOLFF, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by OSTFELD, A. M.
Right arrow Articles by WOLFF, H. G.

Psychosomatic Medicine 19:199-208 (1957)
© 1957 American Psychosomatic Society

Studies in Headache

Summary of Evidence Concerning a Noxious Agent Active Locally During Migraine Headache

ADRIAN M. OSTFELD M.D.1, LORING F. CHAPMAN Ph.D.1, HELEN GOODELL B.S.1, and HAROLD G. WOLFF M.D.1

1 Study Program in Human Health and the Ecology of Man and the Departments of Medicine (Neurology) and Psychiatry, the New York Hospital-Cornell Medical Center, New York, N. Y.

The thesis that during vascular headache of the migraine type there is elaborated locally in extracranial tissues through neurone activity a tissue-damaging and a pain-threshold-lowering agent is supported by the following data:

During a migraine headache attack there predictably occurred lowered deep pain thresholds and edema in those scalp areas in which headache was being experienced. Less commonly, hematomata and painful nodular accumulations of fluid occurred. The lowered deep pain thresholds and edema predictably terminated together, but often outlasted the headache itself.

The bulbar conjunctiva and its vessels on the side of the hemicrania during headache exhibited vasodilatation, edema, burning pain, reduced sensitivity to levarterenol, and increased responsiveness to acetylcholine. The occurrence and duration of vasodilatation, edema, and burning pain were not modified by either topical or parenteral administration of antihistaminic, or anticholinergic agents and were terminated at the same rate after the administration of the vasoconstrictor agents levarterenol and ergotamine tartrate.

Biopsy studies of temporal arteries removed under general anesthesia at a time when these vessels were involved in migraine headaches showed, as compared with temporal arteries removed from nonheadache subjects, perivascular and areolar edema fluid.

The injection of a spreading factor (hyaluronidase) into a tender area of the head during a migraine headache attack increased the area of tenderness fourfold.

Extracranial tissue fluid removed from sites of headache contained increased amounts of one or more amino acids, a finding compatible with the thesis that, locally, protein breakdown is augmented during headache attacks.

This fluid on intracutaneous injection induced erythema and slight lowering of skin pain thresholds. Similar pain-threshold-lowering effects were observed following injection of tissue fluid removed from induced "cold allergy" edema.

Extracranial tissue fluid removed from sites of headache exhibited the capacity to contract the rat uterus.

The combination of temporal artery dilatation (induced by immersion of subjects in warm water) and the pain-threshold-lowering effects of blister fluid injected periarterially resulted in hemicrania on the side of its injection. Serotonin injected periarterially had a similar effect. Such headache was not induced (1) by immersion alone (which induced vasodilatation); (2) by immersion with vasodilatation and the injection of saline; (3) by the injection of blister fluid or saline in the absence of induced vasodilatation. Therefore, cranial artery vasodilatation and the presence locally of a pain-threshold-lowering agent were necessary concomitants to induce headache which had many of the features of migraine headache. The presence of one or more polypeptides, the products of proteolitic activity in tissue fluids, would produce effects compatible with the recorded observations.

Submitted on September 27, 1956




This article has been cited by other articles:


Home page
Psychosom. Med.Home page
F. J. Keefe, M. A. Lumley, A. L. H. Buffington, J. W. Carson, J. L. Studts, C. L. Edwards, D. J. Macklem, A. K. Aspnes, L. Fox, and D. Steffey
Changing Face of Pain: Evolution of Pain Research in Psychosomatic Medicine
Psychosom Med, November 1, 2002; 64(6): 921 - 938.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. P. Friedman
Clinical Observations with 1-Methyl-Lysergic Acid Butanolamide (Uml-491)* in Vascular Headache
Angiology, August 1, 1960; 11(4): 364 - 366.
[PDF]


Home page
ANGIOLOGYHome page
A. M. Ostfeld
Some Aspects of Cardiovascular Regulation in Man*{dagger}
Angiology, February 1, 1959; 10(1): 34 - 42.
[PDF]


Home page
ScienceHome page
L. F. CHAPMAN and H. G. WOLFF
Property of Cerebrospinal Fluid Associated with Disturbed Metabolism of Central Nervous System
Science, November 14, 1958; 128(3333): 1208 - 1209.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1957 by the American Psychosomatic Society